Phase 2-3 AAVance study in MPS IIIA fully on track with seven children already safely treated with LYS-SAF302 Completion of robust two-year natural history study in MPS IIIA to serve as control arm for Phase 2-3 Launch of PROVide, parallel study using home-based smart...
Results of a phase II clinical trial released today in STEM CELLS Translational Medicine (SCTM) indicate that a limbal stem cell (LSC) transplantation is superior to a tissue graft in treating limbal stem cell deficiency syndrome (LSCD). DURHAM, N.C., September 5,...
OWLS (Organizational Wellness and Learning Systems), a science-based consulting and training service in the area of Integral Organizational Wellness™, today announced new findings of a clinical trial that evaluated the efficacy of evidence-based online technology that...
Dual mechanisms, rapid absorption and long half-life support therapeutic potential of AXS-07 in migraine AXS-07 MOMENTUM Phase 3 trial ongoing in migraine patients with history of inadequate response to prior acute treatments NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE)...
Preliminary Phase 1 Data Expected by the End of 2019 Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces that the first patient received investigational therapy in the...
Enrollment Completed for ORION-1 Phase 2b Glaucoma Trial with Data Expected in Q4 2019 Enrollment Near Completion for MIRA-1 Phase 2b Reversal of Mydriasis Trial with Data Expected in Q4 2019 Company to Present at H.C. Wainwright 21st Annual Global Investment...
Email
Text